Advanced International Journal for Research
E-ISSN: 3048-7641
•
Impact Factor: 9.11
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with AIJFR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 6 Issue 6
November-December 2025
Indexing Partners
Innovations in Mucosal Drug Delivery: A Comprehensive Review of Sublingual and Lingual Delivery Devices
| Author(s) | Prof. Dr. Kamalakkannan V, Mr. Gowrishankar Padmanaban, Kugalur Ganesan Parthiban, Dr. Sangameswaran Balakrishnan |
|---|---|
| Country | India |
| Abstract | Mucosal drug delivery via sublingual and lingual routes is increasingly recognized as a transformative approach in pharmaceutical research, owing to its ability to circumvent gastrointestinal degradation and first-pass hepatic metabolism, thus enabling rapid onset and enhanced bioavailability for a diverse range of drugs. Recent innovations in materials science have yielded advanced formulations including nanoencapsulation, mucoadhesive films, multilayered tablets, and bioinspired carriers, which significantly improve drug stability, solubility, and residence time within the oral cavity. Device engineering has progressed with the development of personalized 3D-printed dosage forms, nanoparticle sprays, and microrobotic pills equipped with microstirrers, offering precise, rapid, and efficient drug release even under challenging mucosal conditions. Additionally, digital health integration is reshaping sublingual and lingual delivery systems through biosensor-enabled smart patches and dose-tracking devices, promoting real-time adherence monitoring and feedback-based dosing for improved clinical outcomes. Commercial products have expanded to include rapidly dissolving tablets, transbuccal sprays, and smart device prototypes for a range of indications, such as acute pain, cardiovascular emergencies, and chronic disease management. Despite these advances, challenges like formulation stability, taste masking, and variable patient compliance remain focal points for future research, driving ongoing improvements in technology, education, and regulatory pathways. |
| Keywords | Mucosal drug delivery, Sublingual devices, Lingual devices, Buccal sprays, Nanocarriers |
| Field | Chemistry > Pharmacy |
| Published In | Volume 6, Issue 5, September-October 2025 |
| Published On | 2025-10-30 |
| DOI | https://doi.org/10.63363/aijfr.2025.v06i05.1760 |
| Short DOI | https://doi.org/g99qns |
Share this

E-ISSN 3048-7641
CrossRef DOI is assigned to each research paper published in our journal.
AIJFR DOI prefix is
10.63363/aijfr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.